Facility 1

Torrance, California 90502

0 studies enrolling now · 3 studies all time

What they study most

Insomnia Disorder, Thyroid Cancer

Studies at this site

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) — Completed
• A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile — Completed
• Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2) — Completed